Search

All phases Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 Phase 1/2 Phase 2/3

All statuses Open (recruiting or opening soon) Active, not recruiting Completed

25 miles 50 miles 100 miles 200 miles

Newest Nearest Most relevant

Apply Reset

Study Evaluating Sumanirole for the Treatment of the Signs and Symptoms of Early Parkinson's Disease

Trial Phase 3 Completed June 6, 2006

Study Evaluating Sumanirole for the Treatment of the Signs and Symptoms of Early Parkinson's Disease.

Trial Phase 3 Completed June 6, 2006

Catechol Thioethers in Parkinson's Disease

Trial N/A Completed March 22, 2006

Cohorts and Collections: Clinical and Genetic Study of Parkinson's Disease and Epilepsies

Trial N/A Terminated Feb. 28, 2006

Open Label High Dose Ropinirole (Requip) Study for Patients With Parkinson's Disease

Trial Phase 3 Unknown Feb. 2, 2006

Multifunctional Substrate for Early Detection of Oxidative Stress Susceptibility and Application to Parkinson's Disease

Trial N/A Unknown Dec. 29, 2005

Continued Efficacy and Safety of Apomorphine in Patients With Late-Stage Parkinsons Disease

Trial Phase 3 Completed Dec. 15, 2005

Continued Efficacy of Apomorphine After Previous Exposure of at Least Three Months

Trial Phase 2 Completed Dec. 15, 2005

Neuroprotection and Natural History in Parkinson's Plus Syndromes (NNIPPS)

Trial Phase 3 Terminated Dec. 14, 2005

Treatment of Hallucinosis/Psychosis in Parkinson's Disease by an Investigational Drug

Trial Phase 2 Completed Dec. 6, 2005

Randomized Study of the Effects of Glucose on Cognition in Healthy Young and Elderly People and Parkinson's Disease Patients

Trial N/A Completed Nov. 30, 2005

Efficacy of Therapeutic Interventions for Orthostatic Hypotension in Parkinson's Disease and Multiple System Atrophy

Trial Phase 1 Completed Oct. 19, 2005

Ambulatory Assessment of Motor State in Patients With Parkinson's Disease in Real Daily Life

Trial N/A Unknown Sept. 15, 2005

A Sub-Study With Patients in APO401 to Evaluate Adverse Events During Dose Introduction in Apomorphine-naïve Patients.

Trial Phase 3 Completed Sept. 4, 2005

Long Term Safety and Efficacy of SC Apomorphine in Treatment of "Off" Episodes in Late-Stage Parkinson's Disease

Trial Phase 3 Completed Sept. 1, 2005

Phase II Double Blind Controlled Trial of Nigral Grafting in Patients With Parkinson's Disease

Trial Phase 2 Completed June 23, 2005

Parkinson's Disease Treatment With Coenzyme Q10

Trial Phase 2 Completed June 23, 2005

Continuously Infused Intracerebral (IC) Recombinant-Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (r-metHuGDNF) for the Treatment of Idiopathic Parkinson's Disease

Trial Phase 1 Completed June 23, 2005

Phase II Study of Pallidotomy for Parkinson Disease

Trial Phase 2 Completed June 23, 2005

Study of Axial Mobility Exercises in Parkinson Disease

Trial N/A Completed June 23, 2005